China: Qiming leads $20M series A in Connect Biopharmaceuticals to advance clinical study: https://t.co/5keVUhu5V7
— The Propell Group (@ThePropellGroup) January 29, 2017
#healthtech
China: Qiming leads $20M series A in Connect Biopharmaceuticals to advance clinical study: https://t.co/5keVUhu5V7
— The Propell Group (@ThePropellGroup) January 29, 2017
#healthtech